Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 184 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Home Reported Outcomes in C3G Study

 		C3 Glomerulopathy United States NCT07029542

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

 		Metastatic Hormone-sensitive Prostate Cancer Phase2 Singapore
United States 		NCT06991556

Post Marketing Study on Pluvicto in Korea

 		Metastatic Castration-resistant Prostate Cancer Korea, Republic of NCT06514521

A Multi-center, Ambispective Cohort Study to Evaluate the Impact of Iptacopan for Adult Patients With PNH in China

 		Paroxysmal Nocturnal Hemoglobinuria China NCT06931691

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

 		Metastatic Castration Resistant Prostate Cancer (mCRPC) Phase2 United States NCT06894511

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

 		Atopic Dermatitis Phase2 United States NCT06947993

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

 		Lupus Nephritis Phase3 Hungary
Korea, Republic of
Singapore 		NCT06711887

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

 		Somatostatin Receptor Positive (SSTR+), Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Phase3 Canada
United States 		NCT06784752

Multiple Sclerosis Patient Experience on Kesimpta and Ocrevus Subcutaneous Formulation

 		Multiple Sclerosis United States NCT06668324

RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)

 		Chronic Myelogenous Leukemia in Chronic Phase Saudi Arabia NCT06684964